Skip to content

Clinical evaluation of the analgesic effect of nalbuphine combined with weak opioid anesthesia of Esketamine after laparoscopic cholecystectomy.

Clinical evaluation of the analgesic effect of nalbuphine combined with weak opioid anesthesia of Esketamine after laparoscopic cholecystectomy.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088373
Enrollment
Unknown
Registered
2024-08-16
Start date
2024-02-07
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia after laparoscopic cholecystectomy

Interventions

Group N:The postoperative analgesic drug was nalbuphine 2mg/kg+0.9% sodium chloride solution 100mL.
Group NE1:The postoperative analgesic drug was nalbuphine 2mg/kg+ Esketamine 0.5mg/kg+0.9% sodium chloride solution 100mL.
Group NE2:The postoperative analgesic drug was nalbuphine 2mg/kg+ Esketamine 1mg/kg+0.9% sodium chloride solution 100mL.

Sponsors

Fuyang women and children's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective laparoscopic cholecystectomy under general anesthesia; 2. The age is 18~65 years old; 3. ASA Grade ?~?; 4. Body mass index (BMI) is 18.5 ~ 23.9 kg/m².

Exclusion criteria

Exclusion criteria: 1.Combined with mental and neuropsychological diseases;2.Deaf and dumb people who can't communicate;3.Pregnant and lactating women;4.Used narcotic analgesic drugs within half a year of operation;5.Those who are allergic to drugs during and after operation;6.Acute gallbladder phase

Design outcomes

Primary

MeasureTime frame
VAS pain score;Total and effective compression times of analgesic pump ;

Secondary

MeasureTime frame
General information;The scores of Montreal Cognitive Assessment (MoCA);Ramsay sedation score ;

Countries

China

Contacts

Public ContactHao Wu

Fuyang women and children's hospital

616631064@qq.com+86 135 1558 2018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026